Episode Details
Back to Episodes
Moderna’s mRNA Flu Shot Gets FDA Nod
Published 20 hours ago
Description
Moderna’s new mRNA flu shot, approved by an FDA panel for adults 50+, could revolutionize flu protection—especially for older adults—with faster production and quicker adaptation to new strains, and younger age groups may soon follow.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/4313c4f59752c2ef